Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Neuropeptide Y5 receptor (NPY5R) is a G protein-coupled receptor that binds neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP). It is involved in regulating energy homeostasis, fat accumulation, cell migration and invasiveness, and seizure modulation. NPY5R is considered a therapeutic target for obesity, cancer metastasis, and epilepsy.
Gi/o-mediated inhibition of adenylate cyclase; activation of RhoA/cytoskeleton remodeling
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y5 Receptor (NPY5R).